| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 424,536 | $1,316,061 | $3.10 | 04 Dec 2025 | Direct |
| Esperion Therapeutics, Inc. | Chief Commercial Officer | Stock Option (right to buy) | 380,000 | 04 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 04 Dec 2025 | 2 | $0 | 4 | Chief Commercial Officer | 08 Dec 2025, 16:27 |
| ESPR | Esperion Therapeutics, Inc. | 17 Nov 2025 | 0 | $0 | 3 | Chief Commercial Officer | 17 Nov 2025, 16:08 |